Literature DB >> 8646956

Endoscopic and surgical complications of work-up in screening for colorectal cancer.

J Kewenter1, H Brevinge.   

Abstract

BACKGROUND AND
PURPOSE: In an ongoing randomized screening study of 68,306 patients for early detection of colorectal neoplasm, those with positive Hemoccult II tests (Smith Kline Diagnostic, Sunnyvale, CA) were examined with a flexible sigmoidoscope (FS; 60 cm) and double-contrast barium enema (DCE). The aim of this study was to determine the rate of complications to the work-up.
METHODS: A total of 2,108 FS, 1,987 DCE, 190 colonoscopies, and 104 laparotomies were performed because of a positive Hemoccult.
RESULTS: One patient's large bowel was perforated during diagnostic endoscopy. Four perforations of the large bowel occurred during endoscopic polypectomy (0.8 percent of 513 adenomas removed), and one case of bleeding occurred 12 days after polypectomy. No complications occurred in connection with the 1,987 DCE. Five of 104 laparotomized patients underwent relaparotomy, 3 after removal of a colorectal carcinoma, and 2 of 4 patients with diverticular disease. All five patients healed but required a longer stay at the hospital.
CONCLUSIONS: Complications occurred in 0.3 percent of the endoscopies, and 5 percent of patients had to undergo laparotomy again. No mortality occurred. If mortality attributable to colorectal cancer will decrease because of screening, we find the complication rate is acceptable.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8646956     DOI: 10.1007/bf02056949

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  13 in total

1.  Population-based fecal occult blood screening for colon cancer: will the benefits outweigh the harm?

Authors:  K G Marshall
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

2.  Guidance on large bowel surveillance for people with two first degree relatives with colorectal cancer or one first degree relative diagnosed with colorectal cancer under 45 years.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  Screening options and recommendations for colorectal cancer.

Authors:  Timothy M Geiger; Rocco Ricciardi
Journal:  Clin Colon Rectal Surg       Date:  2009-11

Review 4.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

5.  The evaluation of rectal bleeding in adults. A cost-effectiveness analysis comparing four diagnostic strategies.

Authors:  Elizabeth Allen; Christina Nicolaidis; Mark Helfand
Journal:  J Gen Intern Med       Date:  2005-01       Impact factor: 5.128

6.  A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult.

Authors:  B Towler; L Irwig; P Glasziou; J Kewenter; D Weller; C Silagy
Journal:  BMJ       Date:  1998-08-29

7.  Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.

Authors:  M G Dunlop
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Time to benefit for colorectal cancer screening: survival meta-analysis of flexible sigmoidoscopy trials.

Authors:  Victoria Tang; W John Boscardin; Irena Stijacic-Cenzer; Sei J Lee
Journal:  BMJ       Date:  2015-04-16

9.  Korean guidelines for colorectal cancer screening and polyp detection.

Authors:  Bo-In Lee; Sung Pil Hong; Seong-Eun Kim; Se Hyung Kim; Hyun-Soo Kim; Sung Noh Hong; Dong-Hoon Yang; Sung Jae Shin; Suck-Ho Lee; Dong Il Park; Young-Ho Kim; Hyun Jung Kim; Suk-Kyun Yang; Hyo Jong Kim; Hae Jeong Jeon
Journal:  Clin Endosc       Date:  2012-03-31

Review 10.  Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

Authors:  Øyvind Holme; Michael Bretthauer; Atle Fretheim; Jan Odgaard-Jensen; Geir Hoff
Journal:  Cochrane Database Syst Rev       Date:  2013-10-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.